Sabra Health Care REIT Inc (SBRA) to Issue Quarterly Dividend of $0.45

Sabra Health Care REIT Inc (NASDAQ:SBRA) declared a quarterly dividend on Tuesday, February 5th, NASDAQ reports. Investors of record on Friday, February 15th will be given a dividend of 0.45 per share by the real estate investment trust on Thursday, February 28th. This represents a $1.80 dividend on an annualized basis and a yield of 8.75%. The ex-dividend date of this dividend is Thursday, February 14th.

Sabra Health Care REIT has increased its dividend payment by an average of 4.0% annually over the last three years and has raised its dividend every year for the last 8 years. Sabra Health Care REIT has a dividend payout ratio of 72.9% indicating that its dividend is sufficiently covered by earnings. Analysts expect Sabra Health Care REIT to earn $2.08 per share next year, which means the company should continue to be able to cover its $1.80 annual dividend with an expected future payout ratio of 86.5%.

NASDAQ SBRA traded down $0.16 on Friday, reaching $20.56. 874,599 shares of the company’s stock traded hands, compared to its average volume of 1,441,142. The company has a market capitalization of $3.69 billion, a PE ratio of 8.46, a P/E/G ratio of 2.49 and a beta of 1.02. Sabra Health Care REIT has a fifty-two week low of $15.70 and a fifty-two week high of $23.83. The company has a debt-to-equity ratio of 1.00, a current ratio of 2.88 and a quick ratio of 2.88.

SBRA has been the subject of a number of recent analyst reports. ValuEngine raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Friday, January 4th. SunTrust Banks cut shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating in a report on Tuesday, December 18th. BidaskClub raised shares of Sabra Health Care REIT from a “sell” rating to a “hold” rating in a report on Saturday, December 8th. Bank of America cut shares of Sabra Health Care REIT from a “neutral” rating to an “underperform” rating and cut their price objective for the company from $23.00 to $21.00 in a report on Friday, November 16th. Finally, Raymond James cut shares of Sabra Health Care REIT from an “outperform” rating to a “market perform” rating in a report on Friday, November 16th. Two analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. The company has an average rating of “Hold” and a consensus target price of $21.36.

WARNING: This news story was originally published by WKRB News and is owned by of WKRB News. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.wkrb13.com/2019/02/09/sabra-health-care-reit-inc-sbra-to-issue-quarterly-dividend-of-0-45.html.

About Sabra Health Care REIT

As of September 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 350 Skilled Nursing/Transitional Care facilities, (ii) 91 Senior Housing communities (“Senior Housing – Leased”), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (“Senior Housing – Managed”) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 11 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: What are trading strategies for the 52-week high/low?

Dividend History for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply